133
Participants
Start Date
September 30, 2006
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
erlotinib
Erlotinib 150 mg/day (until progression)
paclitaxel + carboplatine
Paclitaxel 90 mg/m² D1, D8, D15 (D1=D28, until progression) Carboplatine AUC 6 D1 (D1=D28, 6 cycles)
Centre F. Baclesse, Caen
CHU - Pneumologie, Caen
CHU Grenoble - pneumologie, Grenoble
Institut de Cancérologie de la Loire, Saint-Priest-en-Jarez
CHU Lyautey - Pneumologie, Strasbourg
APHP - Saint-Antoine - pneumologie, Paris
APHP - Hopital Tenon - Pneumologie, Paris
Centre Hospitalier - Pneumologie, Belfort
APHP - CHU Avicenne - Oncologie Medicale, Bobigny
Intergroupe Francophone de Cancerologie Thoracique
OTHER